Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: Case report and 8-year follow-up

Transplantation

Volumn 78, Issue 11, 2004, Pages 1582-1589

  Michaels, Marian G ^a   Kaufman, Christina ^b   Volberding, Paul A ^c   Gupta, Phalguni ^a   Switzer, William M ^d   Heneine, Walid ^d   Sandstrom, Paul ^e   Kaplan, Lawrence ^c   Swift, Patrick ^f   Damon, Lloyd ^c   Ildstad, Suzanne T ^b,g  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e HEALTH CANADA   (Canada)

^f Alta Bates Comprehensive Cancer Center   (United States)

^g University of Louisville School of Medicine   (United States)

Author keywords

AIDS; Immune reconstitution; Xenogeneic chimerism; Xenotransplantation; Xenozoonoses

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; INDINAVIR; ITRACONAZOLE; LAMIVUDINE; RECOMBINANT GROWTH HORMONE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAMNESIS; ARTICLE; BABOON; BLOOD; BONE MARROW TRANSPLANTATION; CASE REPORT; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MICROCHIMERISM; NUCLEOTIDE SEQUENCE; ORGAN DONOR; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS LOAD; XENOTRANSPLANTATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANIMALS; BONE MARROW TRANSPLANTATION; FOLLOW-UP STUDIES; HIV-1; HUMANS; LYMPHATIC IRRADIATION; MALE; PAPIO; PILOT PROJECTS; RNA, VIRAL; TRANSPLANTATION, HETEROLOGOUS;

EID: 10644238962     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000141365.23479.4E     Document Type: Article

References (39)

1. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001; 286: 2568.
2. Lane HC, Zunich KM, Wilson W, et al. Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection. Ann Intern Med 1990; 113: 512.
3. Riddell SR, Elliott M, Lewinsohn DA, et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 1996; 2: 216.
4. Morrow WJ, Homsy J, Eichberg JW, et al. Long-term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatment. AIDS Res Hum Retroviruses 1989; 5: 233.
5. Stremlau M, Owens CM, Perron MJ, et al. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004; 427: 848.
6. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168.
7. Ildstad ST, Wren SM, Bluestone JA, et al. Characterization of mixed allogeneic chimeras: Immunocompetence, in vitro reactivity and genetic specificity of tolerance. J Exp Med 1985; 162: 231.
8. Colson YL, Tripp RA, Doherty PC, et al. Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras: functional restriction to host MHC. J Immunol 1998; 160: 3790.
9. Gritsch HA, Glaser RM, Emery DW, et al. The importance of nonimmune factors in reconstitution by discordant xenogeneic hematopoietic cells. Transplantation 1994; 57: 906.
10. Allen MD, Weyhrich J, Gaur L, et al. Prolonged allogeneic and xenogeneic microchimerism in unmatched primates without immunosuppression by intrathymic implantation of CD34+ donor marrow cells. Cell Immunol 1997; 181: 127.
11. Ildstad ST, Wren SM, Boggs SS, et al. Cross-species bone marrow transplantation: Evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment (Rat -> Mouse). J Exp Med 1991; 174: 467.
12. Van Den Brink MR, French SW, Beck TP, et al. Characterization of maturation and function of natural killer cells in xenogeneic (rat - mouse) bone marrow chimeras. Evidence that rat NK cells are present and functional in an xenogeneic environment. Transplantation 1993; 55: 355.
13. Ildstad ST, Wren SM, Sharrow SO, et al. In vivo and in vitro characterization of specific hyporeactivity to skin xenografts in mixed xenogeneically reconstituted mice (B10 + F344 Rat->B10). J Exp Med 1984; 160: 1820.
14. Vallera DA, Blazar BR. T cell depletion for graft-versus-host disease prophylaxis. A perspective on engraftment in mice and humans. Transplantation 1989; 47: 751.
15. Kaufman CL, Colson YL, Wren SM, et al. Phenotypic characterization of a novel bone-marrow derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994; 84: 2436.
16. Michaels MG. Infectious concerns of cross-species transplantation: xenozoonoses. World J Surg 1997; 21: 968.
17. Heneine W, Switzer WM. Highly sensitive and specific polymerase chain reaction assays for detection of baboon and pig cells following xenotransplantation in humans. Transplantation 1996; 62: 1360.
18. Sheehy MJ, Sondel PM, Bach ML, et al. HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes. Science 1975; 188: 1308.
19. Kievits T, van Gemen B, van Strijp D, et al. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J Virol Methods 1991; 35: 273.
20. Pachl C, Todd JA, Kern DG. et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 446.
21. Balachandran R, Thampatty P, Enrico A, et al. Human immuno deficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties. Virology 1991; 180: 229.
22. Michaels MG, Alcendor DJ, St George K, et al. Distinguishing baboon cytomegalovirus from human cytomegalovirus: importance for xenotransplantation. J Infect Dis 1997; 176: 1476.
23. St George K, Rinaldo CR Jr. Effects of enhancing agents on detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1994; 32: 2024.
24. Hayashi K, Ohara N, Teramoto N, et al. An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits. Am J Pathol 2001; 158: 1533.
25. Allan JS, Broussard SR, Michaels MG, et al. Amplification of simian retroviral sequences from human recipients of baboon liver transplants. AIDS Res Hum Retroviruses 1998; 14: 821.
26. Dunning JJ, White DJ, Wallwork J. The rationale for xenotransplantation as a solution to the donor organ shortage. Pathol Biol (Paris) 1994; 42: 231.
27. Starzl TE, Fung J, Tzakis A, et al. Baboon to human liver transplantation. Lancet 1993; 341: 65.
28. DHHS, FDA, CBER. Guidance for industry: public health issues posed by the use of nonhuman primate xenografts in humans. 1-6. Washington, DC, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research (CBER) 1999.
29. Sandmaier BM, McSweeney P, Yu C, et al. Nonmyeloablative transplants: preclinical and clinical results. Semin Oncol 2000; 27: 78.
30. Champlin R. Nonmyeloablative chemotherapy with allogeneic hematopoietic transplantation as adoptive immunotherapy for malignancies. Hematology. Am Soc Hematol 1999; 413.
31. Sharabi Y, Aksentijevich I, Sundt TM, et al. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a non-lethal preparative regimen. J Exp Med 1990; 172: 195.
32. Saper V, Chow D, Engleman ED, et al. Clinical and immunological studies of cadaveric renal transplant recipients given total-lymphoid irradiation and maintained on low-dose prednisone. Transplantation 1988; 45: 540.
33. Klein HG. Will blood transfusion ever be safe enough? Transfus Med 2001; 11: 122.
34. Michaels MG, McMichael JP, Brasky K, et al. Screening donors for xenotransplantation. The potential for xenozoonoses. Transplantation 1994; 57: 1462.
35. Huang LH, Silberman J, Rothschild H, et al. Replication of baboon endogenous virus in human cells. Kinetics of DNA synthesis and integration. J Biol Chem 1989; 264: 8811.
36. Noel PJ, Boise LH, Green JM, et al. CD28 costimulation prevents cell death during primary T cell activation. J Immunol 1996; 157: 636.
37. Halperin EC. Total lymphoid irradiation as an immunosuppressive agent for transplantation and the treatment of "autoimmune" disease: a review. Clin Radiol 1985; 36: 125.
38. Nobler MP, Leddy ME, Huh SH. The impact of palliative irradiation on the management of patients with acquired immune deficiency syndrome. J Clin Oncol 1987; 5: 107.
39. Fultz PN, Schwiebert RS, Su L, et al. Effects of total lymphoid irradiation on SIV-infected macaques. AIDS Res Hum Retroviruses 1995; 11: 1517.